Cellular Immunotherapy for Haematological Malignancies: Beyond Bone Marrow Transplant

• Cellular therapy is changing treatment options for malignant haematology• It has specific application in managing complications of bone marrow transplant• It can be used after failed bone marrow transplant or when it is unsuitable• Greater understanding of immunotherapy has helped differen tiate GVL effects• Barriers to translation include cost, access and limited Phase2/3 clinical trials

Source: Biology of Blood and Marrow Transplantation - November 1, 2017 Category: Hematology Authors: Melita Cirillo, Peter Tan, Marian Sturm, Catherine Cole Source Type: research